Stahl Neil (CIK 0001226689)

Latest company ownership

REGN - REGENERON PHARMACEUTICALS, INC.
Role: EVP Research and Development
Shares held
27,267
Last filed at
Feb 28, 2020
Confidence Score
49.9
2025Q4
Confidence Score History
2017Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 16, 2024 Dec 18, 2024 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 32.5 -304 -0.51% ✗ $222.2K
Dec 9, 2024 Dec 10, 2024 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 30.0 -466 -0.78% ✗ $366.7K
Aug 8, 2024 Aug 12, 2024 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 16.3 -6,097 -9.15% ✗ $5.6M
Aug 2, 2024 Aug 6, 2024 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 15.0 -18,441 -21.67% ✗ $20.2M
Feb 7, 2024 Feb 8, 2024 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 16.3 -8,037 -11.40% ✗ $7.6M
Feb 2, 2024 Feb 6, 2024 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 15.0 -22,713 -24.37% ✗ $21.7M
Dec 8, 2023 Dec 12, 2023 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 17.5 -681 -1.08% ✗ $1.3M
Aug 21, 2023 Aug 23, 2023 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 15.0 -50,000 -44.04% ✗ $41.8M
Nov 8, 2022 Dec 13, 2022 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 20.0 -796 -1.26% ✗ $351K
Feb 18, 2022 Aug 8, 2022 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 15.0 -95,335 -7.78% ✗ $58.2M
Dec 11, 2021 Dec 14, 2021 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 20.0 -753 -1.17% ✗ $500.2K
Nov 29, 2021 Dec 6, 2021 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 15.0 -50,352 -35.83% ✗ $31.8M
Feb 25, 2021 May 18, 2021 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 15.0 -52,935 -20.26% ✗ $27.2M
May 8, 2020 May 11, 2020 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 16.3 -12,500 -24.43% ✗ $7.1M
Apr 13, 2020 Apr 15, 2020 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 3.8 -13,079 -25.29% ✓ $6.7M
Feb 26, 2020 Feb 28, 2020 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 2.5 -25,000 -68.72% ✓ $11.3M
Feb 12, 2020 Feb 14, 2020 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 2.5 -25,000 -39.28% ✓ $10M
Nov 25, 2019 Nov 26, 2019 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 17.5 -10,000 -21.73% ✗ $3.6M
May 24, 2019 Nov 12, 2019 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 17.5 -8,664 -2.77% ✗ $2.5M
May 13, 2019 May 15, 2019 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 16.3 -25,000 -35.88% ✗ $7.6M
May 23, 2018 May 25, 2018 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 16.3 -26,736 -37.47% ✗ $7.9M
Jun 21, 2017 Jun 23, 2017 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 2.5 -20,000 -30.96% ✓ $10.4M
Jun 14, 2017 Jun 16, 2017 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 3.8 -20,295 -31.28% ✓ $9.6M
Jun 1, 2017 Jun 5, 2017 REGENERON PHARMACEUTICALS, INC. EVP Research and Development Sell 36.3 -10,544 -2.36% ✓ $4.9M